EIF5A anticorps (AA 13-27)
-
- Antigène Voir toutes EIF5A Anticorps
- EIF5A (Eukaryotic Translation Initiation Factor 5A (EIF5A))
-
Épitope
- AA 13-27
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EIF5A est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marque
- IHC-plus™
- Specificité
- Human EIF5A. Reported variants NP_001137233.1, NP_001961.1 and NP_001137234.1 represent identical protein:
- Homologie
- Percent identity by BLAST analysis: Human, Gorilla (100%) Monkey, Dog (87%).
- Purification
- Immunoaffinity purified
- Immunogène
-
Synthetic peptide C-RPPHRASFLKRLESK from an internal region (near N-terminus) of human EIF5A (NP_001137232.1). Percent identity by BLAST analysis: Human, Gorilla (100%), Monkey, Dog (87%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product EIF5A Anticorps primaire
-
-
- Indications d'application
-
Approved: IHC, IHC-P (3.75 μg/mL), Peptide-ELISA, WB (1 - 3 μg/mL)
Usage: Western Blot: Approx 20kD band observed in MOLT4 lysates (calculated MW of 20.2kD according to NP_001137232.1). Recommended concentration: 1-3 μg/mL. - Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Minimize freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
- Antigène
- EIF5A (Eukaryotic Translation Initiation Factor 5A (EIF5A))
- Autre désignation
- EIF5A (EIF5A Produits)
- Synonymes
- anticorps EIF-5A, anticorps EIF5A1, anticorps eIF5AI, anticorps EIF5A, anticorps zgc:55504, anticorps zgc:77429, anticorps wu:fb05b06, anticorps wu:fc23f04, anticorps wu:fc61c10, anticorps AA410058, anticorps D19Wsu54e, anticorps Eif4d, anticorps Eif5a1, anticorps eIF-4D, anticorps eIF-5A, anticorps eIF-5A-1, anticorps eIF-5A1, anticorps zgc:77099, anticorps wu:fb17e01, anticorps wu:fb63h04, anticorps wu:fk81e04, anticorps DDBDRAFT_0191442, anticorps DDBDRAFT_0218663, anticorps DDB_0191442, anticorps DDB_0218663, anticorps 1296, anticorps CG3186, anticorps Dmel\\CG3186, anticorps anon-EST:fe2H10, anticorps eIF5A, anticorps eIF5a, anticorps l(2)01296, anticorps EIF-5A1, anticorps NeIF-5A3, anticorps eif5a, anticorps iff-2, anticorps eukaryotic translation initiation factor 5A, anticorps eukaryotic translation initiation factor 5A2, anticorps eukaryotic translation initiation factor 5a, anticorps putative eukaryotic initiation factor 5a, anticorps CG3186 gene product from transcript CG3186-RB, anticorps eukaryotic translation initiation factor 5A-1, anticorps eukaryotic translation initiation factor 5A L homeolog, anticorps EIF5A, anticorps eif5a2, anticorps Eif5a, anticorps eif5a, anticorps tif5A, anticorps Tb11.03.0410, anticorps LOC5579111, anticorps EIF5A1, anticorps eIF-5A, anticorps LOC107820748, anticorps eif5a.L
- Sujet
-
Name/Gene ID: EIF5A
Synonyms: EIF5A, EIF-4D, EIF-5A, EIF-5A-1, EIF-5A1, EIF5A1, Initiation factor 5a, Rev-binding factor, EIF5AI - ID gène
- 1984
- NCBI Accession
- NP_001137232
- UniProt
- P63241
- Pathways
- Regulation of Muscle Cell Differentiation
-